Daniel Javitt

Insider Reports History

Entity
Individual
Location
1201 North Market Street, Suite 111, Wilmington, DE
Signature
Daniel Javitt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Javitt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. 10%+ Owner common stock 9.63M $3.08M $0.32 Nov 30, 2022 by Glytech LLC

Insider Reports Filed by Daniel Javitt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRXP NRX Pharmaceuticals, Inc. Nov 29, 2022 2 -$33.4K 4 Dec 1, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Nov 16, 2022 2 -$171K 4 Nov 18, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Nov 11, 2022 1 -$49.5K 4 Nov 15, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Jul 29, 2022 1 -$791K 4 Aug 2, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Jul 1, 2022 1 $0 4 Jul 5, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Jun 3, 2022 3 -$304K 4 Jun 7, 2022 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Jul 16, 2021 2 $0 4 Nov 2, 2021 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 1 $0 4 Jun 10, 2021 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 0 $0 3 Jun 10, 2021 10%+ Owner